Alexion To Pay $10M To Settle Patent Lawsuit
Alexion Pharmaceuticals Inc. has agreed to pay $10 million to the Oklahoma Medical Research Foundation to settle a patent dispute related to the drug Soliris....To view the full article, register now.
Already a subscriber? Click here to view full article